Melissa C del Rosario1, Vicky Ossowski1, William C Knowler1, Clifton Bogardus1, Leslie J Baier1, Robert L Hanson2. 1. Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, 1550 East Indian School Road, Phoenix, AZ, 85014. 2. Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, 1550 East Indian School Road, Phoenix, AZ, 85014. Electronic address: rhanson@phx.niddk.nih.gov.
Abstract
OBJECTIVE: The aim of this study is to investigate the potential role of DNA methylation in mediating the increased risk of developing type 2 diabetes in offspring of mothers who had diabetes during pregnancy. MATERIALS AND METHODS: Peripheral blood leukocytes were collected from non-diabetic Pima Indians who were either offspring of diabetic mothers (ODM; n=14) or offspring of nondiabetic mothers (ONDM; n=14). The two groups were matched for age, sex, age of mother, and fraction of Pima ethnicity. Differentially methylated regions were determined using a MeDIP-chip assay on an Affymetrix Human Tiling 2.0R Array. Data were analyzed using the model based analysis of tiling arrays (MAT) algorithm, and 4883 regions overlapping with putative promoters, were identified as differentially methylated, having met an empirically derived threshold (nominal p<0.0077). The list of genes with differentially methylated promoters was subjected to KEGG pathway analysis to determine canonical metabolic pathways enriched by these genes. RESULTS: Pathway analysis of genes with differentially methylated promoters identified the top 3 enriched pathways as maturity onset diabetes of the young (MODY), type 2 diabetes, and Notch signaling. Several genes in these pathways are known to affect pancreatic development and insulin secretion. CONCLUSIONS: These findings support the hypothesis that epigenetic changes may increase the risk of type 2 diabetes via an effect on β-cell function in the offspring of mothers with diabetes during pregnancy. Published by Elsevier Inc.
OBJECTIVE: The aim of this study is to investigate the potential role of DNA methylation in mediating the increased risk of developing type 2 diabetes in offspring of mothers who had diabetes during pregnancy. MATERIALS AND METHODS: Peripheral blood leukocytes were collected from non-diabetic Pima Indians who were either offspring of diabetic mothers (ODM; n=14) or offspring of nondiabetic mothers (ONDM; n=14). The two groups were matched for age, sex, age of mother, and fraction of Pima ethnicity. Differentially methylated regions were determined using a MeDIP-chip assay on an Affymetrix Human Tiling 2.0R Array. Data were analyzed using the model based analysis of tiling arrays (MAT) algorithm, and 4883 regions overlapping with putative promoters, were identified as differentially methylated, having met an empirically derived threshold (nominal p<0.0077). The list of genes with differentially methylated promoters was subjected to KEGG pathway analysis to determine canonical metabolic pathways enriched by these genes. RESULTS: Pathway analysis of genes with differentially methylated promoters identified the top 3 enriched pathways as maturity onset diabetes of the young (MODY), type 2 diabetes, and Notch signaling. Several genes in these pathways are known to affect pancreatic development and insulin secretion. CONCLUSIONS: These findings support the hypothesis that epigenetic changes may increase the risk of type 2 diabetes via an effect on β-cell function in the offspring of mothers with diabetes during pregnancy. Published by Elsevier Inc.
Entities:
Keywords:
Immunoprecipitation; In utero; Maternal diabetes; Microarray
Authors: D Dabelea; R L Hanson; R S Lindsay; D J Pettitt; G Imperatore; M M Gabir; J Roumain; P H Bennett; W C Knowler Journal: Diabetes Date: 2000-12 Impact factor: 9.461
Authors: Yoon Shin Cho; Chien-Hsiun Chen; Cheng Hu; Jirong Long; Rick Twee Hee Ong; Xueling Sim; Fumihiko Takeuchi; Ying Wu; Min Jin Go; Toshimasa Yamauchi; Yi-Cheng Chang; Soo Heon Kwak; Ronald C W Ma; Ken Yamamoto; Linda S Adair; Tin Aung; Qiuyin Cai; Li-Ching Chang; Yuan-Tsong Chen; Yutang Gao; Frank B Hu; Hyung-Lae Kim; Sangsoo Kim; Young Jin Kim; Jeannette Jen-Mai Lee; Nanette R Lee; Yun Li; Jian Jun Liu; Wei Lu; Jiro Nakamura; Eitaro Nakashima; Daniel Peng-Keat Ng; Wan Ting Tay; Fuu-Jen Tsai; Tien Yin Wong; Mitsuhiro Yokota; Wei Zheng; Rong Zhang; Congrong Wang; Wing Yee So; Keizo Ohnaka; Hiroshi Ikegami; Kazuo Hara; Young Min Cho; Nam H Cho; Tien-Jyun Chang; Yuqian Bao; Åsa K Hedman; Andrew P Morris; Mark I McCarthy; Ryoichi Takayanagi; Kyong Soo Park; Weiping Jia; Lee-Ming Chuang; Juliana C N Chan; Shiro Maeda; Takashi Kadowaki; Jong-Young Lee; Jer-Yuarn Wu; Yik Ying Teo; E Shyong Tai; Xiao Ou Shu; Karen L Mohlke; Norihiro Kato; Bok-Ghee Han; Mark Seielstad Journal: Nat Genet Date: 2011-12-11 Impact factor: 38.330
Authors: Peng Chen; Paolo Piaggi; Michael Traurig; Clifton Bogardus; William C Knowler; Leslie J Baier; Robert L Hanson Journal: Diabetologia Date: 2017-01-26 Impact factor: 10.122